Feng Zhang, an investigator at the McGovern Institute for Brain Research at MIT and a core member of the Broad Institute, in his laboratory with graduate student Patrick Hsu.

But Feng Zhang, a scientist at the Broad Institute, was first to win a patent on the technique after submitting lab notebooks he says prove he invented it first (see “Who Owns the Biotech ...

By any measure -- papers, prizes, impact -- Zhang is a science superstar, one of the most inventive life scientists in the world. And he’s only 35.

At that moment, Zhang was simply a young father, husband, and son struggling to explain what drives him and why it isn’t unusual for him to arrive home from his lab at 1, 2, or even 3 in the ...

They confirmed that he worked for Feng Zhang at the Broad on CRISPR projects from October 2011 to June 2012. But he added that Lin could not be offered a position to return to the Broad Institute.

Investors bet big on Feng Zhang’s new startup, out to solve one of gene editing’s most vexing problems Aera Therapeutics is launching with $193 million to develop a new nanoparticle technology ...

Feng Zhang’s lab has unveiled a new tool that could be a game changer for the therapeutic delivery of biomolecules: a bacterial "syringe." genprowebdirectory Facebook Linkedin RSS Twitter Youtube ...

Another potentially game-changing discovery has come out of the lab of Feng Zhang, PhD. This time, they uncovered the first programmable RNA-guided system in eukaryotes. Just a few months ago, the ...

Arbor Biotechnologies has raised more than $12 million and claims the gene-editing scientist among its directors, according to a recent federal filing.

CRISPR pioneer Feng Zhang recently achieved a big breakthrough in the delivery of CRISPR gene editing therapies. Zhang used the Cas13 enzyme, whereas most CRISPR therapies in development use Cas9 ...

But Feng Zhang isn’t like most scientists. At 34, the MIT professor is one of the world’s most creative and influential biological engineers, able to see possibilities where others don’t.